FDA issues emergency-use authorization for remdesivir to treat hospitalized patients with severe Covid-19

The experimental drug remdesivir has been approved to t...

Posted: May 2, 2020 10:51 AM

The experimental drug remdesivir has been approved to treat hospitalized patients with severe Covid-19, the US Food and Drug Administration said in a letter on Friday.

Remdesivir is the first authorized therapy drug for Covid-19 in the United States, FDA Commissioner Stephen Hahn said on Friday.

"This is an important clinical advance that showed a statistically significant reduction in time to recovery for patients with Covid-19 and is the first authorized therapy for Covid-19." Hahn said.

The FDA issued an emergency-use authorization on Friday, saying the benefits of the drug outweigh its risks in patients. An emergency-use authorization is a lower regulatory bar than full FDA approval.

Denise Hinton, the FDA's chief scientist, said in the authorization letter that there is "no adequate, approved, and available alternative to the emergency use of remdesivir for the treatment of COVID-19."

The FDA limited its authorization of the drug to adults and children with suspected or laboratory-confirmed Covid-19 and severe disease, which includes low blood oxygen levels, the need for oxygen therapy or the need for a ventilator or other intensive breathing support.

Possible side effects of remdesivir include increased levels of liver enzymes -- which may be a sign of inflammation or damage to cells in the liver -- and infusion-related reactions like low blood pressure, nausea, vomiting, sweating and shivering, the FDA said.

President Donald Trump, speaking in the Oval Office on Friday, called remdesivir a "very promising situation."

"An important treatment for hospitalized corona patients and something I spoke with Dr. Hahn and Dr. (Andrew) Fauci. I spoke with Deborah (Birx) about it. It is really a very promising situation," Trump said.

The federal government is expected to control the distribution of the drug, the FDA letter says, in order to consistently use the drug with the "terms and conditions" of the authorization.

The drug must be administered intravenously. While the optimal dosing is still unknown, Gilead Sciences, the drug's marker, recommends that patients on ventilators take the drug for 10 days and non-ventilator patients only five days.

Gilead has donated the existing supply of the drug, which could cover at least 140,000 treatment courses for patients with Covid-19.

"The company has set a goal of producing at least 500,000 treatment courses by October, 1 million treatment courses by December 2020 and millions more in 2021, if required," the company said in a statement on Friday.

"We will be working very closely to get that to patients, working with FEMA, working with other parts of the government to make sure that we get that to the patients in need as quickly as possible because there are patients out there that can benefit from this medicine today that are hospitalized," said Daniel O'Day, chief executive officer of Gilead Sciences at the Oval Office on Friday. "We don't want any time to waste for that."

O'Day thanked the patients and caregivers who participated in the drug's early clinical trials.

Earlier this week, a government-funded study found that patients who took remdesivir recovered faster than patients who did not. The drug improved recovery time for coronavirus patients from 15 to 11 days. That's similar to the effect that the influenza drug Tamiflu has on flu. Tamiflu also doesn't cure patients quickly, but can reduce how long they are sick.

New York Coronavirus Cases

County data is updated nightly.

Confirmed Cases: 423440

Reported Deaths: 32805
CountyConfirmedDeaths
New York City22916723610
Suffolk439871998
Nassau437952195
Westchester363571447
Rockland13973674
Orange11210491
Erie9033671
Monroe5079285
Dutchess4640153
Onondaga3627200
Albany2636128
Oneida2183115
Ulster208192
Niagara151898
Sullivan149148
Putnam145563
Broome115369
Schenectady108437
Rensselaer78230
Saratoga77417
Columbia55037
Madison41717
Ontario36534
Warren31233
Steuben30142
Fulton30024
Orleans29954
Greene29618
Genesee2805
Herkimer2784
St. Lawrence2634
Wayne2633
Chautauqua2609
Washington26014
Oswego2583
Tompkins2340
Chenango2186
Tioga19425
Chemung1843
Montgomery1794
Livingston1768
Cattaraugus1696
Cayuga1622
Jefferson1420
Clinton1294
Otsego1185
Wyoming1185
Delaware1074
Cortland970
Seneca923
Allegany801
Schoharie690
Yates587
Essex560
Franklin540
Lewis470
Schuyler220
Hamilton80
Unassigned00
Utica
Clear
86° wxIcon
Hi: 85° Lo: 61°
Feels Like: 86°
Oneonta
Overcast
81° wxIcon
Hi: 83° Lo: 58°
Feels Like: 81°
Herkimer
Clear
86° wxIcon
Hi: 86° Lo: 60°
Feels Like: 86°
Thendara
Clear
86° wxIcon
Hi: 80° Lo: 55°
Feels Like: 86°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather
Click here to learn more about A Healthier Mohawk Valley
Ask EPLC Sweepstakes
Saluting Those Who Are Proud 2 Serve
Senior Send-Off brought to you by Herkimer College
WKTV Golf Card - Under 150 left